tyrosine kinase inhibitor
We       demonstrated previously that emodin, a tyrosine kinase inhibitor, suppresses       tyrosine kinase activity in HER-2/neu-overexpressing breast cancer cells and       preferentially represses transformation phenotypes of these cells in vitro.
We       demonstrated previously that emodin, a  @SUBJECT$ ,  @PREDICAT$        tyrosine  @OBJECT$  in HER-2/neu-overexpressing breast cancer cells and       preferentially represses transformation phenotypes of these cells in vitro.